期刊文献+

光学相干断层成像评价不同类型药物洗脱支架置入术后的内膜覆盖 被引量:3

Evaluation on the neointimal coverage post drug-eluting stent implantation by optical coherencetomography
原文传递
导出
摘要 目的应用光学相干断层成像(OCT)对比不同类型药物洗脱支架(DES)置人后的内膜覆盖情况。方法人选62例在我院置人DES(15.3±5.7)个月后行OCT检查的患者,依据置人支架类型分为Cypher支架组(病例数=26,支架数=57)、Endeavor支架组(病例数=17,支架数:23)和Firebird支架组(病例数=19,支架数=32)。对所有支架节段进行OCT检查后应用LightLab系统配备的软件进行图像分析。以64、168和366μm为分界点将增生内膜厚度进行区问划分,评价3种DES的内膜覆盖厚度以及内膜增生的匀称性。结果3组的内膜完全覆盖率差异无统计学意义(P〉0.05)。内膜增生厚度Cypher支架组为(178.7±11.9)μm、Endeavor支架组为(228.7±17.1)μm、Firebird支架组为(170.3±13.3)μm,任意2组间比较差异均有统计学意义(均P〈0.05)。Cypher支架组内膜增生均匀性优于Firebird支架组,Firebird支架组优于Endeavor支架组。结论不同类型DES置入后的内膜覆盖情况存在荠异。OCT可以评价不同类到DES问内障增毕均匀忡的善导. Objective To assess the neointimal coverage after the implantation of various drug eluting stents ( DES ) by optical coherence tomography ( OCT ). Methods The study comprised of 62 patients implanted DES for ( 15.3 ± 5.7 ) months. Patients were divided into three groups according to the type of implanted stent : Cypher group ( patient = 26, stent = 57 ), Endeavor group ( patient = 17, stent = 23 ) and Firebird group (patient = 19, stent = 32). OCT images of the stent were analyzed by software equipped by Light Lab system. Intimal thickness of 64 pμm, 168 μm and 366 μm represents 10% , 25% and 50% lumen area loss, respectively. Neointimal coverage was thin with intimal thickness ≤64 μm, satisfactory with intimal thickness between 65 μm and 366 p,m and hyperplaisa and restenosis with intimal thickness 〉 366 μm. Results The percent of complete neointimal coverage was similar among groups ( P 〉 0.05 ). The thickness of neointimal coverage in Cypher and Endeavor and Firebird group was ( 178.7 ± 11.9 ) μm, (228.7 ± 17. 1 ) μm and ( 170. 3 ± 13.3 ) μm, respectively( all P 〈 0.05 ). The symmetry of Cypher stent was better than Firebird stent, and the symmetry of Firebird stent was better than Endeavoe stent. Conclusion There was significant difference on neointimal coverage after various types of DES implantation, and OCT can be used to evaluate the symmetry of neointimal coverage post implantation of various DES.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2011年第3期204-207,共4页 Chinese Journal of Cardiology
关键词 冠状动脉疾病 支架 体层摄影术 光学相干 增生 Coronary disease Stents Tomography,optical coherence Hyperplasia
  • 相关文献

参考文献14

  • 1Morice MC,Serruys PW,Barragan P,et al.Long-term clinical outcomes with sirolimus-eluting coronary stents:five-year results of the RAVEL trial.J Am Coll Cardiol,2007,50:1299-1304.
  • 2Lotan C,Meredith IT,Mauri L,et al.Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice:12-month data from the E-Five registry.JACC Cardiovasc Interv,2009,2:1227-1235.
  • 3Stone GW,Midei M,Newman W,et al.Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease:a randomized trial.JAMA,2008,299:1903-1913.
  • 4Kandzari DE,Leon MB,Popma JJ,et al.Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease:a randomized controlled trial.J Am Coll Cardiol,2006,48:2440-2447.
  • 5Eisenstein EL,Leon MB,Kandzari DE,et al.Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent:3-year results from the ENDEAVOR Ⅲ trial (randomized controlled trial of the Medtronic Endeavor drug[ABT-578] eluting coronary stent system versus the Cypher sirolimus-eluting coronary stent system in de novo native coronary artery lesions).JACC Cardiovasc Interv,2009,2:1199-1207.
  • 6Matsumoto D,Shite J,Shinke T,et al.Neointimal coverage of sirolimus-eluting stents at 6-month follow-up:evaluated by optical coherence tomography.Eur Heart J,2007,28:961-967.
  • 7Kim JS,Jang IK,Kim JS,et al.Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up:comparison with sirolimus-eluting stents.Heart,2009,95:1907-1912.
  • 8田峰,陈韵岱,孙志军,陈练,刘宏斌,杨庭树,刘长福,金琴花,白启才.光学相干断层成像评价药物洗脱支架置入术后晚期支架贴壁不良[J].中华心血管病杂志,2009,37(7):585-589. 被引量:3
  • 9Rasmussen K,Maeng M,Kaltoft A,et al.Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT Ⅲ):a randomised controlledsuperiority trial.Lancet,2010,375:1090-1099.
  • 10Fajadet J,Wijns W,Laarman GJ,et al.Randomized,doubleblind,multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions:clinical and angiographic results of the ENDEAVOR Ⅱ trial.Circulation,2006,114:798-806.

二级参考文献15

  • 1陈步星,马凤云,罗维,谢文丽,赵希哲,孙淑红,王枫,郭旭梅,褚晓雯.光学相干断层成像在冠心病介入治疗中的应用价值[J].中华心血管病杂志,2006,34(2):130-133. 被引量:19
  • 2Moussa I,Leon MB,Baim DS,et al.Impact of sirolimus-eluting stents on outcome in diabetic patients:a SIRIUS (SIRollm UScoated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.Circulation,2004,109:2273-2278.
  • 3Lomos PA,Hoye A,Goedhart D,et al.Clinical,angiographic,and procedural predictors of angiographic restenosis after sirolimuseluting stem implantation in complex patients:an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study.Circulation,2004,109:1366-1370.
  • 4Kotani J,Awata M,Nanto S,et al.Incomplete neointimal coverage of sirolimus-eluting stents:angioecopic findings.J Am Coll Cardiol,2006,47:2108-2111.
  • 5Jouer M,Finn AV,Farb A,et al.Pathology of dmg-eluting stents in humans:delayed healing and late thrombotic risk.J Am Coll Cerdiol,2006,48:193-202.
  • 6Kume T,Aknsaka T,Kawamoto T,et al.Assessment of coronary intima media thickness by optical coherence tomography:comparison with intravascular ultrasound.Circ J,2005,69:903-907.
  • 7Matsumoto D,Shire J,Shinke T,et al.Neointimel coverage of sirolimus-eluting stents at 6-month follow-up:evaluated by optical coherence tomography.Eur Heart J,2007,28:961-967.
  • 8Kame T,AkasakaT,Kawamoto T,et al.Assessment of coronary arterial thrombns by optical coherence tomngrapby.Am J Cardiol,2006,97:1713-1717.
  • 9Hoffmann R,Morico MC,Moses JW,et al.Impact of late incomplete stcnt opposition after sirolimus-eluting stent implantation on 4-year clinical events:intravascular ultrasound analysis from the multicontre,randomised,RAVEL,E-SIRIUS and SIRIUS trials.Heart,2008,94:322-328.
  • 10Takano M,Inami S,Jang IK,et al.Evaluation by optical coherence tomngraphy of neointimal coverage of sirolimus-eluting atent three months after implantation.Am J Cardiol,2007,99:1033-1038.

共引文献2

同被引文献16

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部